How Does Cancer Spread?

0
Cancer cells

Cancer cells

Cancer is most dangerous when it has spread, or metastasized, from its original site in the body. A tumor that began as an isolated mass – often treatable by surgery and/or radiation therapy – can become a dispersed, much more difficult to treat, malignancy.

For cancer to spread, several steps must occur. As a result of genetic mutations or other changes, cells in a once travel-averse tumor develop a biological wanderlust. They gain the ability to break free from their neighbors and survive untethered from the original tumor mass. One way they manage to invade and crawl through surrounding tissue is by switching on genes otherwise reserved for use in fetal development.

Eventually, these renegade cells encounter a blood or lymph vessel, which provides a kind of highway system to the rest of the body. Slipping into the vessel, they ride the current of blood or lymph to a new site. There, they make their way through the vessel walls, and establish residence. Continuing their frantic pace of growth and division, they eventually form a new colony, tapping into the body’s bloodstream for nutrients and growth stimulants. The result is a metastasis of the original cancer.

Metastasis is not inevitable for any type of solid tumor. It occurs only when a sequence of genetic changes occurs that allow the cancer cells to undertake and survive each stage of their journey from their initial location, and only when the body’s natural defenses are unable to stop them. Even then, many metastatic cancers lie dormant for years before they begin to grow again, if at all.

A great deal of research is underway to understand the genetic alterations that endow cancer cells with metastatic ability, and to deprive them of the capacity to spread.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dr. Matthew Davids explores combining ibrutinib with FCR (iFCR) for younger patients with previously-untreated chro… https://t.co/wzVpo47tSa
Dana-Farber @danafarber
“We’re changing the way people are cared for, through #precisionmedicine, precision care, and a total team approach… https://t.co/RnZXsH2rW8
Dana-Farber @danafarber
Cell-weighing method could help doctors choose #cancer drugs: https://t.co/YesjtyxIvR via @MIT https://t.co/0F7wsZSuLJ

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.